Effects of nitric oxide on cell proliferation: novel insights.

[1]  R. Arai,et al.  S-nitrosoglutathione and endothelial nitric oxide synthase-derived nitric oxide regulate compartmentalized ras S-nitrosylation and stimulate cell proliferation. , 2013, Antioxidants & redox signaling.

[2]  J. Hare,et al.  Regulation of cardiovascular cellular processes by S-nitrosylation. , 2012, Biochimica et biophysica acta.

[3]  C. Napoli,et al.  Adult stem cells and the clinical arena: are we able to widely use this therapy in patients with chronic limbs arteriopathy and ischemic ulcers without possibility of revascularization? , 2012, Cardiovascular & Hematological Agents in Medicinal Chemistry.

[4]  R. Ferrari,et al.  Insight into the Mode of Action of ACE Inhibition in Coronary Artery Disease , 2012, Drugs.

[5]  P. Anversa,et al.  Role of Cardiac Stem Cells in Cardiac Pathophysiology: A Paradigm Shift in Human Myocardial Biology , 2011, Circulation research.

[6]  S. Souchelnytskyi,et al.  Protein tyrosine nitration in the cell cycle. , 2011, Biochemical and biophysical research communications.

[7]  A. Takahashi,et al.  Nitric oxide radical-induced radioadaptation and radiosensitization are G2/M phase-dependent. , 2011, Journal of radiation research.

[8]  S. Cadenas,et al.  Nitric oxide signaling: classical, less classical, and nonclassical mechanisms. , 2011, Free radical biology & medicine.

[9]  A. Roguin,et al.  Nitric oxide: a key factor behind the dysfunctionality of endothelial progenitor cells in diabetes mellitus type-2. , 2011, Cardiovascular research.

[10]  M. Kibbe,et al.  Effect of nitric oxide on neointimal hyperplasia based on sex and hormone status. , 2011, Free radical biology & medicine.

[11]  R. Fiscus,et al.  Essential roles of the nitric oxide (no)/cGMP/protein kinase G type‐Iα (PKG‐Iα) signaling pathway and the atrial natriuretic peptide (ANP)/cGMP/PKG‐Iα autocrine loop in promoting proliferation and cell survival of OP9 bone marrow stromal cells , 2011, Journal of cellular biochemistry.

[12]  C. Napoli,et al.  Endothelial progenitor cells as therapeutic agents in the microcirculation: an update. , 2011, Atherosclerosis.

[13]  Robin A. J. Smith,et al.  Mitochondria-targeted antioxidants as therapies. , 2011, Discovery medicine.

[14]  M. Watkins,et al.  S-glutathionylation uncouples eNOS and regulates its cellular and vascular function , 2011 .

[15]  Junfeng Zhang,et al.  Selective fluorescent activation for bioimaging the expression of nitric oxide in cellular and in vivo systems. , 2011, Methods in molecular biology.

[16]  E. Troncy,et al.  Involvement of the nitric oxide-soluble guanylyl cyclase pathway in the oxytocin-mediated differentiation of porcine bone marrow stem cells into cardiomyocytes. , 2011, Nitric oxide : biology and chemistry.

[17]  A. Hmadcha,et al.  Low concentrations of nitric oxide delay the differentiation of embryonic stem cells and promote their survival , 2010, Cell Death and Disease.

[18]  J. Friedman,et al.  Sustained release nitric oxide from long-lived circulating nanoparticles. , 2010, Free radical biology & medicine.

[19]  Xuming Dai,et al.  Endothelial Nitric Oxide Synthase Deficiency Causes Collateral Vessel Rarefaction and Impairs Activation of a Cell Cycle Gene Network During Arteriogenesis , 2010, Circulation research.

[20]  C. Napoli,et al.  Therapeutic angiogenesis in diabetic apolipoprotein E-deficient mice using bone marrow cells, functional hemangioblasts and metabolic intervention. , 2010, Atherosclerosis.

[21]  J. Stamler,et al.  S-Nitrosylation in Cardiovascular Signaling , 2010, Circulation research.

[22]  S. Narumiya,et al.  Prostaglandin I2 Promotes Recruitment of Endothelial Progenitor Cells and Limits Vascular Remodeling , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[23]  S. Lippard,et al.  Fluorescent probes to investigate nitric oxide and other reactive nitrogen species in biology (truncated form: fluorescent probes of reactive nitrogen species). , 2010, Current opinion in chemical biology.

[24]  M. Gladwin,et al.  Nitrite Potently Inhibits Hypoxic and Inflammatory Pulmonary Arterial Hypertension and Smooth Muscle Proliferation via Xanthine Oxidoreductase–Dependent Nitric Oxide Generation , 2010, Circulation.

[25]  U. Förstermann,et al.  Prevention of atherosclerosis by interference with the vascular nitric oxide system. , 2009, Current pharmaceutical design.

[26]  E. Weitzberg,et al.  NO generation from inorganic nitrate and nitrite: Role in physiology, nutrition and therapeutics , 2009, Archives of pharmacal research.

[27]  Tetsuo Nagano,et al.  Bioimaging Probes for Reactive Oxygen Species and Reactive Nitrogen Species , 2009, Journal of clinical biochemistry and nutrition.

[28]  A. Jekabsone,et al.  Nitric oxide protects the heart from ischemia-induced apoptosis and mitochondrial damage via protein kinase G mediated blockage of permeability transition and cytochrome c release , 2009, Journal of Biomedical Science.

[29]  Agustina Garcı́a,et al.  NO-sensitive guanylyl cyclase beta1 subunit is peripherally associated to chromosomes during mitosis. Novel role in chromatin condensation and cell cycle progression. , 2009, The international journal of biochemistry & cell biology.

[30]  M. Kibbe,et al.  Nitric oxide regulates the 26S proteasome in vascular smooth muscle cells. , 2009, Nitric oxide : biology and chemistry.

[31]  F. Murad,et al.  Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells , 2008, Proceedings of the National Academy of Sciences.

[32]  C. Napoli,et al.  Beneficial effects of autologous bone marrow cell infusion and antioxidants/L-arginine in patients with chronic critical limb ischemia , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[33]  R. de Caterina,et al.  The prostacyclin analogue iloprost increases circulating endothelial progenitor cells in patients with critical limb ischemia , 2008, Thrombosis and Haemostasis.

[34]  Takuya Terai,et al.  Fluorescent probes for bioimaging applications. , 2008, Current opinion in chemical biology.

[35]  C. Napoli,et al.  Therapeutic dose of nebivolol, a nitric oxide-releasing beta-blocker, reduces atherosclerosis in cholesterol-fed rabbits. , 2008, Nitric oxide : biology and chemistry.

[36]  C. Harris,et al.  The chemical biology of nitric oxide: implications in cellular signaling. , 2008, Free radical biology & medicine.

[37]  A. Mai,et al.  Nitric Oxide Modulates Chromatin Folding in Human Endothelial Cells via Protein Phosphatase 2A Activation and Class II Histone Deacetylases Nuclear Shuttling , 2008, Circulation research.

[38]  Virgil L. Woods,et al.  Nitrosyl-Cobinamide, a New and Direct Nitric Oxide–Releasing Drug Effective In Vivo , 2007, Experimental biology and medicine.

[39]  S. Moncada,et al.  Nitric oxide and mitochondrial signaling: from physiology to pathophysiology. , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[40]  C. Napoli,et al.  Therapeutic Effects of Autologous Bone Marrow Cells and Metabolic Intervention in the Ischemic Hindlimb of Spontaneously Hypertensive Rats Involve Reduced Cell Senescence and CXCR4/Akt/eNOS Pathways , 2007, Journal of cardiovascular pharmacology.

[41]  R. Ferrari,et al.  Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent. , 2007, Pharmacological research.

[42]  J. Harlan,et al.  GEA 3162, a peroxynitrite donor, induces Bcl-2-sensitive, p53-independent apoptosis in murine bone marrow cells , 2007, Biochemical pharmacology.

[43]  Po-Len Liu,et al.  High Glucose Impairs Early and Late Endothelial Progenitor Cells by Modifying Nitric Oxide–Related but Not Oxidative Stress–Mediated Mechanisms , 2007, Diabetes.

[44]  J. Poderoso,et al.  Mitochondrial nitric oxide in the signaling of cell integrated responses. , 2007, American journal of physiology. Cell physiology.

[45]  P. Galuppo,et al.  Endothelial Nitric Oxide Synthase Uncoupling Impairs Endothelial Progenitor Cell Mobilization and Function in Diabetes , 2007, Diabetes.

[46]  Xiangru Lu,et al.  Lack of endothelial nitric oxide synthase decreases cardiomyocyte proliferation and delays cardiac maturation. , 2006, American journal of physiology. Cell physiology.

[47]  H. Mori,et al.  Beraprost sodium enhances neovascularization in ischemic myocardium by mobilizing bone marrow cells in rats. , 2006, Biochemical and biophysical research communications.

[48]  A. Villalobo.  Nitric oxide and cell proliferation , 2006, The FEBS journal.

[49]  F. Murad,et al.  Proteomic modification by nitric oxide. , 2006, Journal of pharmacological sciences.

[50]  C. Napoli,et al.  Beneficial effects of concurrent autologous bone marrow cell therapy and metabolic intervention in ischemia-induced angiogenesis in the mouse hindlimb. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. P. McCoy,et al.  cGMP-independent nitric oxide signaling and regulation of the cell cycle , 2005, BMC Genomics.

[52]  A. Avogaro,et al.  Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. , 2005, Journal of the American College of Cardiology.

[53]  C. Caldarera,et al.  Nitric oxide mediates either proliferation or cell death in cardiomyocytes. Involvement of polyamines , 2005, Amino Acids.

[54]  U. Walter,et al.  Vasodilator-Stimulated Phosphoprotein Regulates Proliferation and Growth Inhibition by Nitric Oxide in Vascular Smooth Muscle Cells , 2004 .

[55]  J. Loscalzo,et al.  Nitric Oxide and Other Novel Therapies for Pulmonary Hypertension , 2004, Journal of cardiovascular pharmacology and therapeutics.

[56]  庭野 和生.  Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells : Close link between PGI2 signal and NO pathways , 2004 .

[57]  C. Napoli,et al.  Nitric oxide-releasing drugs. , 2003, Annual review of pharmacology and toxicology.

[58]  U. Förstermann,et al.  Regulation of the Expression of Inducible Nitric Oxide Synthase , 2003, Biological chemistry.

[59]  M. Kurabayashi,et al.  Transcriptional Stimulation of the eNOS Gene by the Stable Prostacyclin Analogue Beraprost Is Mediated Through cAMP-Responsive Element in Vascular Endothelial Cells: Close Link Between PGI2 Signal and NO Pathways , 2003, Circulation research.

[60]  C. Cobelli,et al.  L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach. , 2003, Diabetes.

[61]  F. Murad,et al.  Nitric oxide (NO): Biogeneration, regulation, and relevence to human diseases , 2003 .

[62]  F. Murad,et al.  Nitric oxide (NO)--biogeneration, regulation, and relevance to human diseases. , 2003, Frontiers in bioscience : a journal and virtual library.

[63]  G. Gurtner,et al.  Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular Structures , 2002, Circulation.

[64]  E. Ackah,et al.  Chronic treatment with nitric oxide-releasing aspirin reduces plasma low-density lipoprotein oxidation and oxidative stress, arterial oxidation-specific epitopes, and atherogenesis in hypercholesterolemic mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[65]  J. Loscalzo,et al.  Nitric oxide donors and cardiovascular agents modulating the bioactivity of nitric oxide: an overview. , 2002, Circulation research.

[66]  G. Condorelli,et al.  Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation‐sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  L. Ignarro,et al.  Nitric Oxide Inhibits Ornithine Decarboxylase viaS-Nitrosylation of Cysteine 360 in the Active Site of the Enzyme* , 2001, The Journal of Biological Chemistry.

[68]  P. Vadiveloo,et al.  Lipopolysaccharide-induced cell cycle arrest in macrophages occurs independently of nitric oxide synthase II induction. , 2001, Biochimica et biophysica acta.

[69]  C. Napoli,et al.  Nitric oxide and atherosclerosis. , 2001, Nitric oxide : biology and chemistry.

[70]  C. Napoli,et al.  Effects of nitric oxide-releasing aspirin versus aspirin on restenosis in hypercholesterolemic mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[71]  C. Cooper,et al.  Nitric oxide synthases: structure, function and inhibition. , 2001, The Biochemical journal.

[72]  Simon C Watkins,et al.  Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. , 2000, Journal of vascular surgery.

[73]  E. Nabel,et al.  Nitric oxide modulates expression of cell cycle regulatory proteins: a cytostatic strategy for inhibition of human vascular smooth muscle cell proliferation. , 2000, Circulation.

[74]  M. Gu,et al.  Nitric Oxide Increases p21Waf1/Cip1 Expression by a cGMP-dependent Pathway That Includes Activation of Extracellular Signal-regulated Kinase and p70 S6k * , 2000, The Journal of Biological Chemistry.

[75]  D. Hui,et al.  Apolipoprotein E inhibition of vascular smooth muscle cell proliferation but not the inhibition of migration is mediated through activation of inducible nitric oxide synthase. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[76]  U. Ikeda,et al.  Endogenously generated nitric oxide by nitric-oxide synthase gene transfer inhibits cellular proliferation. , 2000, The Journal of pharmacology and experimental therapeutics.

[77]  T. Sasaguri,et al.  Tumor Suppressor p53 But Not cGMP Mediates NO-Induced Expression of p21Waf1/Cip1/Sdi1 in Vascular Smooth Muscle Cells , 1999 .

[78]  R. Heller,et al.  Nitric oxide inhibits proliferation of human endothelial cells via a mechanism independent of cGMP. , 1999, Atherosclerosis.

[79]  Ram V. Sharma,et al.  NOS gene transfer inhibits expression of cell cycle regulatory molecules in vascular smooth muscle cells. , 1999, American journal of physiology. Heart and circulatory physiology.

[80]  E. Moilanen,et al.  Inhibition of human lymphocyte proliferation by nitric oxide-releasing oxatriazole derivatives. , 1997, European journal of pharmacology.

[81]  K J Gooch,et al.  Exogenous, basal, and flow‐induced nitric oxide production and endothelial cell proliferation , 1997, Journal of cellular physiology.

[82]  H. Nojima,et al.  Induction of the Cyclin-dependent Kinase Inhibitor p21Sdi1/Cip1/Waf1 by Nitric Oxide-generating Vasodilator in Vascular Smooth Muscle Cells* , 1997, The Journal of Biological Chemistry.

[83]  L. Hung,et al.  cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. , 1997, Circulation.

[84]  R. Sarkar,et al.  Dual cell cycle‐specific mechanisms mediate the antimitogenic effects of nitric oxide in vascular smooth muscle cells , 1997, Journal of hypertension.

[85]  R. Furchgott.  Introduction to EDRF Research , 1993, Journal of cardiovascular pharmacology.

[86]  G. Rubanyi,et al.  The role of endothelium in cardiovascular homeostasis and diseases. , 1993, Journal of cardiovascular pharmacology.

[87]  U. Garg,et al.  Nitric oxide-generating vasodilators inhibit mitogenesis and proliferation of BALB/C 3T3 fibroblasts by a cyclic GMP-independent mechanism. , 1990, Biochemical and biophysical research communications.